Archived Events
Archived Events
-
Jun 23, 2020 at 10:30 AM EDT BMO 2020 Prescriptions for Success Healthcare Conference (Virtual)
-
Jun 4, 2020 at 3:00 PM EDT KRYSTEXXA Immunomodulation Strategy and EULAR Data
Supporting Materials
-
Jun 2, 2020 at 1:00 PM EDT Jefferies 2020 Virtual Healthcare Conference
-
May 6, 2020 at 8:00 AM EDT Horizon Therapeutics First Quarter 2020 Earnings Call
Supporting Materials
Q1 2020 Earnings Release 384.3 KBQ1 2020 Presentation 1.6 MBQ1 2020 Conference Call Remarks 139.4 KB -
Apr 2, 2020 at 8:00 AM EDT Horizon Acquisition of Curzion (4/2/20)
-
Mar 3, 2020 at 12:00 PM EST Cowen and Company 40th Annual Health Care Conference
-
Feb 26, 2020 at 8:00 AM EST Horizon Therapeutics Fourth Quarter 2019 Earnings Call
Supporting Materials
Q4 2019 Earnings Release 345.4 KBQ4 2019 Presentation 4.6 MBQ4 2019 Conference Call Remarks 167.7 KB -
Jan 21, 2020 at 5:00 PM EST FDA Approval of Teprotumumab/TEPEZZA™
-
Jan 15, 2020 at 5:00 PM PST 38th Annual J.P. Morgan Healthcare Conference - Presentation
-
Dec 3, 2019 at 12:00 PM EST Piper Jaffray 31st Annual Healthcare Conference
-
Nov 20, 2019 at 8:00 AM GMT Jefferies 2019 London Healthcare Conference
-
Nov 19, 2019 at 9:45 AM EST Stifel 2019 Healthcare Conference
-
Nov 6, 2019 at 8:00 AM EST Horizon Therapeutics Third Quarter 2019 Earnings Call
Supporting Materials
Q3 2019 Earnings Release 389.6 KBQ3 2019 Presentation 1.8 MBQ3 2019 Conference Call Remarks 778.7 KB -
Sep 10, 2019 at 10:00 AM EDT Morgan Stanley 17th Annual Global Healthcare Conference
-
Aug 7, 2019 at 8:00 AM EDT Horizon Therapeutics Second Quarter 2019 Earnings Call
Supporting Materials
Q2 2019 Earnings Release 401 KBQ2 2019 Presentation 1.1 MBQ2 2019 Conference Call Remarks 159.5 KB -
Jun 20, 2019 at 10:00 AM EDT JMP Securities Life Sciences Conference
-
May 8, 2019 at 8:00 AM EDT Horizon Therapeutics First Quarter 2019 Earnings Call
Supporting Materials
Q1 2019 Earnings Release 797.6 KBQ1 2019 Presentation 414.4 KBQ1 2019 Conference Call Remarks 149.4 KB -
Apr 29, 2019 Dr. R. Douglas’s AACE IR TED/OPTIC Presentation
-
Feb 28, 2019 at 8:00 AM EST Overview of Teprotumumab OPTIC Phase 3 Trial Topline Results and Thyroid Eye Disease (TED)
Supporting Materials
-
Oct 4, 2018 at 10:30 AM EDT Overview of Thyroid Eye Disease (TED) and Teprotumumab Clinical Data
Supporting Materials
-
Nov 9, 2017 at 10:00 AM EST KRYSTEXXA ACR Investor Webcast & Presentation
Supporting Materials